EUVIMEDEUVIMED entdecken
Crossref

Evaluation of adherence to antipsychotics: A real‐world data study using four different dosing assumptions

Marina Fuente-Moreno, Alexandra L Dima iD, Maria Rubio-Valera, Luisa Baladon, Victor Chavarria, Salvatore Fabrizio Contaldo, Carlos Peña-Salazar, Vicky Serra-Sutton, Patricia Hermida-González, Jorge Peláez de Loño, Maria Eugènia Rey-Abella, Ignacio Aznar-Lou und 1 weitere

British Journal of Clinical Pharmacology · 2024-06 · 90 (6) · 1480-1492

DOI: 10.1111/bcp.16042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 18.03.2024. Verfasst von Marina Fuente-Moreno und 12 weiteren Autor:innen. Beteiligte Einrichtung: Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Teaching, Research & Innovation Unit, Parc Sanitari Sant Joan…. Hauptthemen laut MEDLINE: Antipsychotic Agents, Drug Monitoring. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aimed to assess the frequency of dosing inconsistencies in prescription data and the effect of four dosing assumption strategies on adherence estimates for antipsychotic treatment.

Methods

A retrospective cohort, which linked prescription and dispensing data of adult patients with ≥1 antipsychotic prescription between 2015‐2016 and followed up until 2019, in Catalonia (Spain). Four strategies were proposed for selecting the recommended dosing in overlapping prescription periods for the same patient and antipsychotic drug: (i) the minimum dosing prescribed; (ii) the dose corresponding to the latest prescription issued; (iii) the highest dosing prescribed; and (iv) all doses included in the overlapped period. For each strategy, one treatment episode per patient was selected, and the Continuous Medication Availability measure was used to assess adherence. Descriptive statistics were used to describe results by strategy.

Results

Of the 277 324 prescriptions included, 76% overlapped with other prescriptions (40% with different recommended dosing instructions). The number and characteristics of patients and treatment episodes (18 292, 18 303, 18 339 and 18 536, respectively per strategy) were similar across strategies. Mean adherence was similar between strategies, ranging from 57 to 60%. However, the proportion of patients with adherence ≥90% was lower when selecting all doses (28%) compared with the other strategies (35%).

Conclusion

Despite the high prevalence of overlapping prescriptions, the strategies proposed did not show a major effect on the adherence estimates for antipsychotic treatment. Taking into consideration the particularities of antipsychotic prescription practices, selecting the highest dose in the overlapped period seemed to provide a more accurate adherence estimate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsDrug MonitoringHumansRetrospective StudiesFemaleSpainMaleMiddle AgedAdultDose-Response Relationship, DrugAgedDrug PrescriptionsPractice Patterns, Physicians'

Stichwörter der Autor:innen

antipsychotic agentselectronic health recordsmedication adherencepharmacoepidemiologyprescribing patternsreal‐world data

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Teaching, Research & Innovation Unit, Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat,…
  • Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
  • Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Madrid, Spain.
  • Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.
  • Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS); Health Quality and Assessment Agency of Catalonia, Barcelona, Spain.

ORCID-Profile: Alexandra L Dima

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Fuente-Moreno, M., Dima, A. L., Rubio-Valera, M., Baladon, L., Chavarria, V., Contaldo, S. F., Peña-Salazar, C., Serra-Sutton, V., Hermida-González, P., de Loño, J. P., Rey-Abella, M. E., Aznar-Lou, I., & Serrano-Blanco, A. (2024). Evaluation of adherence to antipsychotics: A real‐world data study using four different dosing assumptions. British Journal of Clinical Pharmacology, 90(6), 1480-1492. https://doi.org/10.1111/bcp.16042

Vancouver

Fuente-Moreno M, Dima AL, Rubio-Valera M, Baladon L, Chavarria V, Contaldo SF, et al. Evaluation of adherence to antipsychotics: A real‐world data study using four different dosing assumptions. British Journal of Clinical Pharmacology. 2024;90(6):1480-1492. doi:10.1111/bcp.16042

BibTeX
@article{FuenteMoreno2024,
  author = {Fuente-Moreno, Marina and Dima, Alexandra L and Rubio-Valera, Maria and Baladon, Luisa and Chavarria, Victor and Contaldo, Salvatore Fabrizio and Peña-Salazar, Carlos and Serra-Sutton, Vicky and Hermida-González, Patricia and de Loño, Jorge Peláez and Rey-Abella, Maria Eugènia and Aznar-Lou, Ignacio and Serrano-Blanco, Antoni},
  title = {Evaluation of adherence to antipsychotics: A real‐world data study using four different dosing assumptions},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  volume = {90},
  number = {6},
  pages = {1480--1492},
  doi = {10.1111/bcp.16042}
}
Kostenlos starten →